Hepcinat LP

Listing ID #3551276

22,500 / Box

Get Latest Price

MOQ 3 Box
Disease NameHepatitis C
Supply Type Exporter, Supplier
Preferred Buyer Location All over the world

View More Details

Product Details

Natco Hepcinat LP (Ledipasvir + Sofosbuvir) - Harvoni is a new medication used to treat hepatitis C. It is a combination pill containing sofosbuvir (sold separately as Sovaldi) plus ledipasvir. It was approved in Europe in November 2014 for treatment of adults with genotype 1 or 4 chronic hepatitis C, and for some people with genotype 3. For many people with these genotypes, Harvoni is an interferon-free and ribavirin-free hepatitis C treatment option. Some people with harder-to-treat disease may do better if they add ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Additional Information

Payment Terms L/C, D/P, T/T
Packaging Details NA
Delivery Time 5 - 10 days

Company Details

Pragati Healthcare is an Indian FDA (CDSCO) and DGFT (Directorate General of Foreign Trade) approved pharmaceutical exporter of wide range of specialty medical products. We are an ISO 9001:2015 certified organisation, registered with Ministry of Health and Pharmaceutical Export Promotion Council of India. We are also a registered vendor for Ministry of Defence, India.
We specialize in export of Tender supplies, Named Patient Programme Supplies, Orphan Drug Supplies, Temperature Controlled Shipments and Biosimilar Therapies.
Product Range: Branded/Biosimilar/Generic formulations for treatments of :
Oncology, Organ Transplant, Osteoporosis, Rheumatoid Arthritis, Hepatitis, HIV, Multiple Sclerosis, Cardiology, Diabetes, Vaccine Immunizations and Blood Derivatives.